CCRN:NSD-Cross Country Healthcare Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 25.31

Change

+0.38 (+1.52)%

Market Cap

USD 0.97B

Volume

0.24M

Avg Analyst Target

USD 22.33 (-11.76%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Cross Country Healthcare Inc (CCRN) Stock Analysis:
Based on the Cross Country Healthcare Inc stock forecasts from 5 analysts, the average analyst target price for Cross Country Healthcare Inc is USD 22.33 over the next 12 months. Cross Country Healthcare Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cross Country Healthcare Inc is Slightly Bearish, which is based on 6 positive signals and 10 negative signals. At the last closing, Cross Country Healthcare Inc’s stock price was USD 25.31. Cross Country Healthcare Inc’s stock price has changed by -0.85 % over the past week, +1.86 % over the past month and +176.91 % over the last year.

About

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment offers t ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

+2.10 (+3.69%)

USD5.05B 47.80 13.90
AMED Amedisys Inc

+7.72 (+5.34%)

USD4.44B 21.70 12.97
AMEH Apollo Medical Holdings Inc

+5.22 (+6.87%)

USD4.20B 47.12 27.40
ENSG The Ensign Group Inc

+1.61 (+2.06%)

USD4.17B 23.05 16.65
SGRY Surgery Partners Inc

+2.50 (+5.23%)

USD4.04B 63.00 17.96
LHCG LHC Group Inc

+7.86 (+6.66%)

USD3.74B 28.42 15.02
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
ADUS Addus HomeCare Corporation

+2.68 (+2.99%)

USD1.35B 35.38 20.22
CMPS COMPASS Pathways plc

+1.27 (+4.64%)

USD1.33B N/A N/A
AVAH Aveanna Healthcare Holdings In..

+0.35 (+5.64%)

USD1.31B N/A 10.97

ETFs Containing CCRN

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 185.34% 81% B- 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 185.34% 81% B- 97% A+
Trailing 12 Months  
Capital Gain 176.91% 86% B 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 176.91% 86% B 96% A
Trailing 5 Years  
Capital Gain 67.28% 44% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.28% 44% F 63% D
Average Annual (5 Year Horizon)  
Capital Gain 19.84% 48% F 66% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.84% 48% F 65% D
Risk Return Profile  
Volatility (Standard Deviation) 78.31% 43% F 22% F
Risk Adjusted Return 25.33% 48% F 39% F
Market Capitalization 0.97B 48% F 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.61 83% B 53% F
Price/Book Ratio 4.62 46% F 27% F
Price / Cash Flow Ratio 35.57 20% F 12% F
EV/EBITDA 13.81 60% D- 48% F
Management Effectiveness  
Return on Equity 32.40% 90% A- 93% A
Return on Invested Capital 7.45% 54% F 72% C-
Return on Assets 10.74% 100% A+ 93% A
Debt to Equity Ratio 34.60% 35% F 46% F
Technical Ratios  
Short Ratio 2.91 60% D- 48% F
Short Percent 4.33% 39% F 36% F
Beta 1.02 38% F 56% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector